Nessun titolo diapositiva
Download
Report
Transcript Nessun titolo diapositiva
La TME robotica
a. coratti – m. di marino
UO Chirurgia Generale, Grosseto
Laparoscopic surgery
ADVANTAGES
DRAWBACKS
• Pain control
• Unnatural movements
• Blood losses negligible
• Poor ergonomics for the surgeon
• Immunitary system
• Reduced degrees of freedom
• Shorter ileus
• Abdominal wall
• Dissociated visual-mechanical
control
• Morbidity
• Bidimensional vision
• Post-op stay
• Limited sutures
Robotic surgery
Robotic surgery
The new system “da Vinci SI HD”
OVERCOMES LAPAROSCOPIC PITFALLS
3D / HD vision
Fine dissection
Deep, small operating fields
High precision suturing
Easier setup
Tutoring
Robotic surgery
ENDO-WRIST ™ SYSTEM
6 degrees of freedom
Tremor elimination
Motion scaling
Robotic surgery in Grosseto
October 2000 – September 2012
Total series
General Surgery
First period
2000 – 2007
732
General Surgery
Second period
2007 – 2012
393
Urology/gynecologist -
2007 – 2012
298
TOTAL
2000 – 2012 1423
Robotic rectal resection
Reported series
Author
Year Refer.
Pts.
Op. time
Conversion Morbidity
Mortality
(min)
D’Annibale*
2004
Dis Colon
Rectum
53
240
9.4%
15%
0
Hellan
2007
Ann Surg
Oncol
39
285
2.6%
12.1%
0
Baik
2008
Surg
Endosc
9
220.8
0
0
0
Spinoglio*
2008
Dis Colon
Rectum
50
338.8
4%
14%
0
Choi
2009
Surg
Endosc
13
260.8
0
23%
0
Luca*
2009
Ann Surg
Oncol
55
290
0
12.7%
0
* Including colonic resections
Robotic rectal resection
No randomized prospective study – 66 pts
Casciola (JSLS 2009)
Short- and medium-term outcome of robot-assisted and traditional
laparoscopic rectal resection.
Robotic rectal resection
Casciola (JSLS 2009)
Intraoperative and pathologic data
Robotic rectal resection
Casciola (JSLS 2009)
Early and long-term outcomes
Robotic rectal resection
Casciola (JSLS 2009)
Oncological results
(NS)
Local recurrence
ROB: 0
LAP: 5.4%
(NS)
Conclusions
Robot-assisted rectal surgery is a safe and
feasible procedure that facilitates
laparoscopic total mesorectal excision.
Robotic rectal resection
Retrospective multicentric study – 143 pts
Pigazzi et Al (Ann Surg Oncol 2010)
Multicentric Study on Robotic Tumor-Specific Mesorectal Excision
for the Treatment of Rectal Cancer.
Procedure
112 RAR, 31APR
Conversion (%)
4.9%
Mean blood loss
283ml
Mean op time
297min
N. harvested nodes
14.1 (± 6.5)
Distal margin
2.9cm (± 1.8)
Negative radial margin
142/143 (99.3%)
Robot-assisted rectal
surgery is a safe and
feasible procedure that
may facilitate mesorectal
3Y survival
97%
excision.
Local recurrence
0 (mean follow-up 17.4 months)
Conclusions
Experience in Grosseto
Perioperative results: 58 pts. (2001-2012)
Procedures
LAR
APR
44
14
Hybrid technique
Full robotic
33
25
Preop CHT/RT
46/58 (79,3%)
Open conversions
1/58 (1.7%)
Operative time
288min (range: 120-420)
Blood loss
Negligible
Ileostomy (LAR)
41/44(93.3%)
Morbidity
9/58 (15,5%)
Redo surgery
5/58 (8,6%)
Mortality
0
Mean hospital stay
7.9 days (range: 4-40)
Pathology
Rectal carcinoma
Large rectal adenoma
Anal carcinoma
Anal melanoma
51
3
2
2
NO intraoperative blood transfusions
Anastomotic leakage 2, pelvic abscess 1, bowel
occlusion 1, postoperative bleeding 1 (VLS redo)
Experience in Grosseto
Oncological outcomes - Rectal carcinoma
TNM of rectal
carcinomas
(51 cases)
yT0N0
Stage I
Stage II
Stage III
Stage IV
5
25
10
10
1
Retrieved
lymph nodes
11.3 (range: 5-30)
Resection margins
R0 in all cases
Mean follow-up
44.2 months (range: <1-118)
Recurrence
Local: 0
Port site: 0
Distant MTS: 6/51 (11,7%)
Related cancer
mortality
3,9% (2/51)
Liver 2, peritoneum 3, inguinal nodes 1
Experience in Grosseto
Long term survival (DFS, OS) - Rectal carcinoma
3-Years overall survival (OS)
3-Years disease free survival (DFS)
Experience in Grosseto
Functional outcomes: 58 pts. (2001-2012)
Urinary dysfunction
1.7% (1/58)
Sexual dysfunction
Males: 6.9% (2/29)
Total: 5,1% (3/58)
Faecal incontinence
5.8% (2/34; 8 pts. are waiting for closure of ileostomy)
(LAR)
Soiling
(LAR)
8.8% (3/34; 8 pts. are waiting for closure of ileostomy)
Rectal robotic surgery
Technical aspects
SURGICAL STRATEGY
Full robotic
technique
Hybrid (lap/rob)
technique
Surgical steps
Patient positioning
Robotic cart
Ports
■ ROBOTIC
■ LAPAROSCOPY
■ ROBOTIC
Docking 1
. Paziente supino
. Posizione ginecologica
. Arti super. Addotti
. Anti-trendelenburg 30 °
. Ruotato sul fianco destro
di 15 °
. Carello robotico dalla
spalla sinistra
Docking 2
. Paziente supino
. Posizione ginecologica
. Arti super. Addotti
. Trendelenburg 25 °
. Ruotato sul fianco destro
di 15 °
. Carello robotico dalla
gamba sinistra
Posizionamento dei trocars
I step
ottica
II step
ottica
R1
R2
R2
Ass
R3
R3
Ass
Ass
Ass
R1
minilaparomia
Posizionamento dei trocars
I step
ottica
II step
ottica
R1
R2
R2
Ass
R3
R3
Ass
Ass
Ass
R1
Minilaparotomia
Personal experience
Very difficult at the beginning
Ports positioning
Cart docking
Pelvic exposure
Time consuming
Laparoscopy it’s better?
Personal experience
Very difficult at the beginning
Intermediate experience
Switch from hybrid to full robotic
Changing in port and cart setup
Personal experience
Very difficult at the beginning
Intermediate experience
Advanced experience
Full robotic technique
Starting by pelvic dissection
Ultralow intersphyncteric dissection
No return to laparoscopy!
Robot-assisted LAR - I step
video
Robot-assisted LAR – II step
video
Rectal robotic surgery
Technical aspects
ADVANTAGES
3D/HD vision - Endowrist
TME
Nerves sparing
Intersphynteric dissection
Pelvic dissection (deep, narrow)
Obese patients
Reduction of conversions (?)
Rectal robotic surgery
Technical aspects
DRAWBACKS
Large operating field
Change of cart/patients positioning
Bowel retraction
Expert assistant surgeon
High cost procedure
Conclusions
Robot-assisted rectal resection are feasible and safe.
The robotic technique may improve TME, nerves sparing and
intersphynteric dissection in ultralow rectal resection.
Major advantages can be appreciated in males, in narrow and deep
pelvis, and in obese patients.
The long-term functional and oncological results are very interesting.
We are waiting the ROLARR trial.
Scuola ACOI di Chirurgia Robotica
www.roboticschool.it
COURSES 2012
BASIC
May, 21-25
1st ADVANCED
(Upper GI, HPB, Endocrine)
June, 25-29
2nd ADVANCED
(Colorectal, HPB, Endocrine)
November, 26-30